Cerebral venous thrombosis in a patient of paroxysmal nocturnal haemoglobinuria following aplastic anaemia

Case report OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-08-05 ⓘ

This case report details a patient with aplastic anemia who developed cerebral venous thrombosis and was subsequently diagnosed with paroxysmal nocturnal hemoglobinuria, discussing the potential relationship between these conditions and immunosuppressive therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A young lady who had aplastic anaemia presented for cerebral venous thrombosis after five years of follow up. She was diagnosed to have paroxysmal nocturnal haemoglobinuria. She had received immunosuppressive therapy with methylprednisolone, cyclosporine-A, anti-lymphocyte globulin, danazol and pregnenolone. The relation between aplastic anaemia, paroxysmal nocturnal haemoglobinuria and cerebral venous thrombosis is discussed. The role of immunosuppressive therapy for aplastic anaemia in causation of paroxysmal nocturnal haemoglobinuria is reviewed.

My notes (saved in your browser only)

MeSH descriptors

Anemia, Aplastic Hemoglobinuria, Paroxysmal Sagittal Sinus Thrombosis Adult Anemia, Aplastic Anemia, Aplastic Female Hemoglobinuria, Paroxysmal Humans Immunosuppressive Agents Immunosuppressive Agents Magnetic Resonance Imaging Sagittal Sinus Thrombosis Sagittal Sinus Thrombosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

SciLite annotations

chemicals 4
prednisolone oleanoglycotoxin-a danazol pregnenolone

Source provenance

openalex
last seen: 2026-05-10T11:47:42.047208+00:00
pubmed
last seen: 2026-10-08T21:00:08.490831+00:00
scilite
last seen: 2026-05-18T04:57:49.680383+00:00
License: CC0 · commercial use OK